
From left to right: Megan Godfrey, Judith Schvimmer and Jennifer Guild.
Leading up to our annual Women to Watch feature, Marijuana Venture senior editor Patrick Wagner had the pleasure of interviewing three remarkable members of the Abstrax’s team: senior vice president of marketing Megan Godfrey, chief legal officer Judith Schvimmer and vice president of regulatory and quality Jennifer Guild.
Terpene manufacturer Abstrax is winning both critical and commercial success. The Irvine-based business has seen 282% growth in the past three years, was recognized as a Best Workplaces for Innovators by Fast Company in 2024 and was named on the Inc. 5000 in 2024 and 2025. Godfrey, Schvimmer and Guild are helping fuel that success and are helping the company chart its path forward.
Megan Godfrey | Senior vice president of marketing
Can you tell me a little about the challenges in marketing Abstrax products to cannabis companies and areas where you have found success?
Megan Godfrey: Cannabis is definitely a unique industry to market in. A lot of the traditional tools marketers rely on just aren’t available to us
… as I’m sure you already know. Advertising is restricted, social platforms can be unpredictable (as long as they aren’t getting shut down), and we even have to be careful about how we talk about our products. So we’ve had to get pretty creative.
Where we’ve really found our sweet spot is education and science. Instead of just saying, “Here’s a new product, buy it,” we talk about what we discovered, why it matters to the community and how it can help our customers. We also share a lot of our research even when there isn’t a direct commercial benefit to us. We really believe that if we can help move the industry forward, everyone benefits.
Tell me a little about a standout milestone?
Godfrey: One of my favorite moments was when our R&D team discovered the compounds responsible for gas aroma in cannabis.
It was so awesome to watch how one discovery touched every team in our company and then started making waves outside of Abstrax too. It changed the conversation around what actually creates cannabis aroma and challenged some of what the industry had believed for years.
That was one of those moments where you realize the work you’re doing can have an impact way beyond your own company.
Can you give me any sort of metric that exemplifies the success of Abstrax’s marketing?
Godfrey: One of the numbers I care about most is new customer growth. I want to know that Marketing is actually helping grow the business, not just generating impressions and engagement.
We’ve seen new customer acquisition grow as much as 78% year over year, which means we were bringing in nearly twice as many new customers as the year before.
Now we’re taking that even further and looking at marketing contributed revenue and how our leads move through the Sales pipeline. At the end of the day I want to connect what Marketing is doing not only to revenue and customer growth, but also to how we nurture and support customers throughout their entire lifecycle.
Judith Schvimmer | Chief legal officer
How has your previous experience in the wine industry overlapped with your current role in cannabis?
Judith Schvimmer: Great question! There is a lot of overlap between these two spaces, as well as with the craft beer industry, where I also spent some of my career. These are all crop-based products, with a lot of science and artisanship necessary to turn them into what you sell, so that presents different business complexities. Alcoholic beverage and cannabis face some similar headwinds right now, with some decreases or changes in consumption trends. They are also all highly regulated, and you need to navigate federal, state, local, and international regulations (sometimes while they’re still being written and rewritten). And importantly, these products are all meant for people’s pleasure, which are enjoyable spaces to work within, but they also come with a high responsibility of care for consumer and public safety.
What has been the most challenging/interesting aspect of your current role?
Schvimmer: Relating back to your first question, I started my career in intellectual property law, before moving on to wine, beer, functional beverages, nutraceuticals, and regulated cannabis. And here I am, at a science-led company that develops and sells flavor ingredients for cannabis, beer, beverage, and wellness products. I wish I could say it had been planned that way — it wasn’t — but it’s constantly interesting to see the overlaps happen and be able to carry forward all of those past roles.
What is on the horizon for you at Abstrax?
Schvimmer: We are in full growth mode right now. We just built out our headquarters in Irvine, bringing in smart manufacturing capabilities and getting our R&D scientists, quality and labs folks, and our marketing and sales teams all under the same roof, and next we’ll finish the customer-facing innovation center. It will be an exciting year as we continue to grow into new verticals and take advantage of our building expansion. Personally, I plan to be busy supporting this company growth, helping to solve the challenges that come from growth and from a rapidly changing cannabis and hemp legal landscape, and enjoying being a part of the Abstrax team.
Jennifer Guild | Vice president of regulatory and quality
Did you have any apprehension about joining the cannabis industry?
Jennifer Guild: Not really. If anything, I was excited by the opportunity to be on the cusp of building an entirely new regulatory pathway. My career had already given me experience working across food, pharmaceutical and cosmetic regulatory frameworks, and cannabis presented this fascinating opportunity to ask: What can we learn from established industries, which best practices translate, and where does cannabis need to develop standards of its own?
There aren’t many points in a regulatory professional’s career when you get to participate in an industry while its regulatory framework is still being built. I saw an opportunity to identify best practices from mature industries around quality, safety, toxicology, manufacturing and responsible product development, and then help determine how they could be thoughtfully adapted to cannabis rather than simply copied over.
On a more personal level, I went to UC Santa Cruz, so cannabis was hardly foreign to me. It had been part of the cultural landscape around me long before I ever imagined I would have a professional role in the industry. Being able to bring my scientific and regulatory background into a field that had been relevant throughout my adult life felt much more exciting than intimidating.
I started collaborating with Abstrax before joining the company full-time in 2022, so I also had the benefit of seeing the company’s approach firsthand. What ultimately attracted me was its willingness to invest in science even when there wasn’t a regulation requiring it. That aligned very closely with how I believe a responsible company should operate.
What continues to motivate me is that we are still building that framework. Cannabis regulation is maturing quickly, but there remains an enormous opportunity for industry, scientists and regulators to work together to develop standards that are practical, scientifically defensible and genuinely protective of consumers without unnecessarily limiting consumer choice or responsible innovation.
You joined the company in 2022. Could you tell me about a particular career milestone or achievement you’ve made at the company?
Guild: One of the things I’m most proud of is helping build a regulatory program that doesn’t just respond to regulations, but also helps generate the science needed to inform them.
A great example is our work on inhalation safety. Cannabis vape products developed much faster than the science and regulatory infrastructure surrounding the non-cannabinoid ingredients used in them. Rather than relying on the fact that many flavor ingredients have long histories of use in food, we recognized that inhalation is a fundamentally different route of exposure and deserved its own evaluation.
That work ultimately became a multiyear, multimillion-dollar research effort involving independent toxicologists and accredited laboratories to evaluate the chemistry, toxicology and real-world aerosol behavior of ingredients used in inhalable cannabis products. We deliberately structured the work to answer difficult questions rather than produce predetermined outcomes.
I’m particularly proud of that because it represents what I think regulatory leadership should look like in an emerging industry.
What is on the horizon for you at Abstrax?
Guild: A major focus for me is taking what we’ve learned internally and helping translate it into better standards for the broader industry.
Cannabis regulation is entering a different stage of maturity. Regulators are increasingly asking more sophisticated questions about ingredient identity, source, toxicology, aerosol chemistry and what actually constitutes a cannabis-authentic product. Those are good questions, but the answers need to be grounded in science rather than assumptions about whether an ingredient is “natural” or “artificial/synthetic”.
Abstrax has invested heavily in understanding cannabis chemistry at a level that simply wasn’t possible a decade ago, including advanced two-dimensional gas chromatography and extensive toxicological research. I see an important part of my role going forward as helping translate that science into practical regulatory frameworks through engagement with regulators, standards organizations, trade associations and the scientific community.
Internally, I’m also focused on continuing to build a Regulatory and Quality organization that can scale with the company. Ultimately, my goal is the same in both places: make good science easier to translate into responsible products and sensible regulation.
Marijuana Venture’s 2026 Women to Watch feature was sponsored by Leading Retirement Solutions
Leading Retirement Solutions (LRS) is a women-owned national retirement plan service provider that helps businesses design, implement, and manage retirement plans tailored to their unique goals and workforce needs. With over a decade in the cannabis industry, LRS helps operators offer competitive 401(k) plans and employee benefits through customized plan design, administration, consulting, and recordkeeping services. LRS helps employers strengthen financial futures for both their organizations and workforce.



